Funds for Healthcare 'ROAI' Platform Optura

Nashville, TN-based Optura, which helps healthcare clients measure and optimise the ROI of their AI investments, has announced $17.5 million in Series A funding, with which to continue its own investment in expanding AI capabilities, platform teams and LLM partnerships.

The company says the sector will spend more than $18 billion on AI this year - 46% of all healthcare investment - but to date 95% of enterprise GenAI pilots have produced 'no measurable value.' Optura's ROAI platform maps an organization's existing data into a unified knowledge layer; scores and ranks use cases against organizational priorities, cost and readiness; translates the top priorities into healthcare-specific AI agents; simulates the expected return in advance of deployment; and then rolls out the AI agents across the enterprise, tracking outcomes, initiatives and projected value into a unified, real-time dashboard. As of now more than $2 billion-worth of AI initiatives are 'loaded in.'

Co-founder and CEO Andy Fanning comments: 'The hundreds of AI use cases coupled with the introduction of foundational models into healthcare markets, like Claude for Healthcare, are driving AI spend and increasing risk. It has also created a never-ending menu of point solutions, without an objective framework to help healthcare leaders measure the ROI on their AI investment decisions. We developed Optura to take out that guesswork and help healthcare organizations objectively measure results.'

The funding, which adds to $10m raised earlier, was led by Salesforce Ventures, with participation from Echo Health Ventures and continued investment from Susa Ventures, Matrix Partners and HC9 Ventures.

Web site: www.optura.ai .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.